The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa
- PMID: 9199408
- DOI: 10.1006/jmbi.1997.1029
The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa
Abstract
Tissue Factor Pathway Inhibitor (TFPI) is a 36 kDa glycoprotein that helps maintain haemostasis by inhibiting Factor Xa and the Factor VIIa/Tissue Factor (TF) complex. TFPI contains three tandemly linked Kunitz inhibitor domains, of which the second inhibits factor Xa. We have undertaken a multidisciplinary approach to study the structure and function of the second Kunitz domain of TFPI, with a view towards the rational design of factor Xa inhibitors. Amino acid residues 93 to 154 of the mature TFPI protein, corresponding to the second Kunitz domain (TFPI-kII), were expressed in Escherichia coli. The protein was purified to near homogeneity by ion exchange, hydrophobic interaction, and size exclusion chromatography, respectively. TFPI-kII is a potent factor Xa inhibitor with a Ki of 1.5 x 10(-10) M, a value that does not differ significantly from that of intact TFPI. The three-dimensional structure of TFPI-kII in aqueous solution was determined by 1H nuclear magnetic resonance spectroscopy (NMR). A set of 30 conformers was calculated with the program DIANA using 906 distance constraints derived from nuclear Overhauser effects and 23 dihedral angle constraints. This set, representing the solution structure of TFPI-kII, has an average root-mean-square deviation of 0.78 A for the backbone atoms and 1.38 A for all heavy atoms of residues 1 to 58. The structure of TFPI-kII has also been determined in complex with porcine trypsin using X-ray crystallographic techniques. The complex has been solved to a resolution of 2.6 A, with a final R-factor of 16.2%. Comparison of the NMR derived structure with that of TFPI-kII in complex with trypsin reveals little divergence of the two structures, with the exception of residue Tyr17. Superposition of the trypsin:TFPI-kII complex on factor Xa provides insights into macromolecular determinants for the inhibition of factor Xa. Complexation would require a degree of reorganisation of factor Xa residues, in particular of TyrF99, but also perhaps of the F148-loop. The interaction was further investigated using restrained molecular dynamics. Electrostatic interactions would appear to play a major role. The reorganisation of factor Xa is in contrast to the proposed factor Xa:TAP interaction, where TAP would bind to the "ground state" structure of factor Xa.
Similar articles
-
The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.Thromb Haemost. 2001 Mar;85(3):458-63. Thromb Haemost. 2001. PMID: 11307815
-
Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.Biochem J. 2002 Oct 15;367(Pt 2):451-8. doi: 10.1042/BJ20020696. Biochem J. 2002. PMID: 12117418 Free PMC article.
-
Structure and biology of tissue factor pathway inhibitor.Thromb Haemost. 2001 Oct;86(4):959-72. Thromb Haemost. 2001. PMID: 11686353 Review.
-
Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor.Thromb Haemost. 1998 Oct;80(4):585-7. Thromb Haemost. 1998. PMID: 9798974
-
The lipoprotein-associated coagulation inhibitor.Prog Hemost Thromb. 1991;10:243-68. Prog Hemost Thromb. 1991. PMID: 2008533 Review.
Cited by
-
Structural biology of factor VIIa/tissue factor initiated coagulation.Front Biosci (Landmark Ed). 2012 Jun 1;17(7):2476-94. doi: 10.2741/4066. Front Biosci (Landmark Ed). 2012. PMID: 22652793 Free PMC article. Review.
-
Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI).J Biol Chem. 2014 Jan 17;289(3):1732-41. doi: 10.1074/jbc.M113.533836. Epub 2013 Nov 25. J Biol Chem. 2014. PMID: 24275667 Free PMC article.
-
A Kunitz-type inhibitor from tick salivary glands: A promising novel antitumor drug candidate.Front Mol Biosci. 2022 Aug 16;9:936107. doi: 10.3389/fmolb.2022.936107. eCollection 2022. Front Mol Biosci. 2022. PMID: 36052162 Free PMC article. Review.
-
Structural, Biochemical Characterization and Molecular Mechanism of Cerastokunin: A New Kunitz-Type Peptide with Potential Inhibition of Thrombin, Factor Xa and Platelets.Protein J. 2024 Aug;43(4):888-909. doi: 10.1007/s10930-024-10226-9. Epub 2024 Aug 2. Protein J. 2024. PMID: 39095592
-
A reusable impedimetric aptasensor for detection of thrombin employing a graphite-epoxy composite electrode.Sensors (Basel). 2012;12(3):3037-48. doi: 10.3390/s120303037. Epub 2012 Mar 6. Sensors (Basel). 2012. PMID: 22736991 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous